logo
更新:2019-06-16
Clinical QC
面议
上海  | 10-15年  | 硕士  | 社招  | 招1人
已结束
职位详情

Responsibilities:
 Oversees the development and implementation of Quality Control strategy and activities for Clinical Operation team. Oversees generation, review and compliance of developed and approved procedures with company-wide quality policies and standards.


 Responsible for the development, maintenance and the communication of high quality standards in the delivery of clinical studies. 


 Secures and improves quality in Clinical Operation by providing training, implementing QC activities and driving quality initiatives.


 Provides compliance and process advice to study teams and identifies opportunities for quality and process improvements.  


 Responsible for the development, implementation and continuing review of  procedural documents, and maintains current knowledge and understanding of regulations and industry practices in relation to clinical trials.


 Supports audits and inspections and is the main contact for auditors from Clinical Operation team.  Advises and monitors Clinical Operation team in the planning and implementation of all quality control activities and uses risk management to evaluate compliance issues and develop solutions.


 Provide co-monitoring visit according to the alignment with study lead.
• Ensures annual study and system QC plan in place, facilitates and monitors the implementation of QC activities by Clinical Operation team.
• Analyses quality status of the function, identifies risk/root cause and comes up with CAPA
• Advises Clinical Operation team on CRO quality management
• Advises/Supports the local study team in the preparation for, conduct of and responses to audits and regulatory inspections.
• Advises local study team in the resolution of the findings in audit and inspection reports. Gives regular feedback/training on audit and inspection findings to Clinical Operation team.
• Shares learnings from audits and inspections with  study team. Identifies and ensures resolution of potential risks based on previous study/systems QC results, audit and inspection results.
• Works with LMs to ensure the training compliance within function
• Identifies and organises/provides on-going and ad hoc training to Clinical Operation staff according to training needs
 introductory training to new staff, including Procedural Training
 ad hoc local training solutions e.g. as result of serious or recurring quality issues
 (be involved in) other initiatives to identify and share best practices
• Identifies opportunities for quality improvement and optimizing/simplifying relevant processes
• Provides training to Investigational Site staff on GCP, ICH and local regulations, if support needed by local study team
• Creates an environment of strong team spirit, timely and effective communications, sense of urgency, high motivation and inspires teams to achieve goals in the immediate and long term . To be an active and visible change agent, promoting flexible and open mindsets to new opportunities.
Minimum Requirements and Preferred Background
• University degree in related discipline, preferably in life science, or equivalent.
• Fluent knowledge of spoken and written English.
• At least 5 years experience in the multinational pharmaceutical industry, preferably in Clinical Development
• Proceudral Documents generating experience
• Good understanding of the drug development process and related GXP activities
• Good understanding of the skills and knowledge required for the successful delivery of a clinical study, eg. ICH-GCP, study management, site management, monitoring and local regulations
• Good knowledge of local and international regulations and guidelines


• Ability to monitor the internal and external working enviroment and enable changes to drive quality, simplication and efficiency
• Ability to look for and champion more efficient and effective methods/processes of delivering quality clinical trials with reduced budget and in less time.
• Excellent written and verbal communication skills
• Excellent ability to prioritse and handle multiple tasks
• Good  analytical, problem solving, negotiation and conflict resolution skills.
• Demonstrated ability to set and manage priorities, performance targets and project initiatives in a global environment
• Strong interpersonal skills, with the ability to work effectively with others at all levels of the organization
• Excellent cultural awareness.
• Integrity and high ethical standards
工作地址
上海市浦东新区
点击查看地图
公司介绍
On Nov. 27th, 2017, through a joint venture between AstraZeneca and China Advanced Manufacturing Fund, Dizal Pharma was co-constructed as a world-leading innovative bio-pharmaceutical enterprise. As a new, unique mode of cooperation between SDIC Fund Management Company Ltd. and worldwide privileged research resources in the field of biological pharmacy, Dizal Pharma can not only accelerate the launch and listing of global new drugs in China, bring Chinese patients access to the latest drugs found across the world at once and thus raise the clinical benefits of patients; At the same time, we also take advantages of the global privileged innovative resources, increase China’s core competitive power in the innovation of new drugs, step in the leading branch of international research and development of new drugs and push China into the role of causing both huge and powerful influence in pharmacy industry.
As a new-style joint venture company, besides the project of the transfer of AstraZeneca’s patents, Dizal Pharma also develops the innovation and creation of global First-in-Class drugs.

The R&D (Research and Development) team of Dizal Pharma was AstraZeneca Asia and Emerging Market Research Center. As one of AstraZeneca’s first four R&D centers across the world, it dedicated to analyze the potential scientific mechanism of those most common diseases in Asia and fulfill the particular medical needs of Asian patients. It was one of the few R&D centers established by transnational pharmacy enterprises in China which had the ability to actually research, develop and produce micro-molecular new drugs, the ability to develop produce new drugs independently and completely, and the first-class medical platform in the world.

       迪哲医药,于2017年10月独立运营,是一家研发驱动型生物医药企业,致力于全球创新药物(First-in-class/ Best-in-class)探索、研发以及商业化。

       迪哲医药的前身为阿斯利康亚洲及新兴市场创新研发中心,设立于中国上海,是阿斯利康全球四个研发中心之一(另三个中心分别位于英国剑桥、瑞典哥德堡、美国盖瑟斯堡);是国际一流、高产出的创新药研发机构,拥有全球领先的转化医学和新药分子设计与筛选技术平台;在恶性肿瘤、自身免疫性疾病、肾病等重大疾病的新药研究方面积累了丰富经验。

工商信息
以下信息来自
企业类型
有限责任公司(中外合资)
经营状态
存续
行业类型
研究和试验发展
成立日期
2017年10月27日
注册地址
无锡市新吴区净慧东路汇融商务广场E楼(5号楼)4105室
统一社会信用代码
91320214MA1T6H5736
若用人单位提供虚假招聘信息,以担保或其他任何名义收取财物,扣押或以保管为名索要证件,都属于违法行为,应当提高警惕。
发布于